Fig. 1 · Structure

Documents & Downloads

CCT-251921

CDK8 inhibitor

CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor with an IC50 of 2.3 nM.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CDK8 IC50 2.3 nM
CDK19 IC50 2.6 nM

Cellular Effect

Cell Line Activity Value Description Reference
MV4-11 GI50 0.05 μM Antiproliferative activity against human MV4-11 cells assessed as growth inhibition after 72 hrs by resazurin assay [PMID: 33823391]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1607837-31-9
Applications CDK8 inhibitor
Formula C21H23ClN6O
Molecular Weight 410.9
SMILES
O=C1NCCC12CCN(C3=C(Cl)C(N)=NC=C3C4=CC5=C(N(C)N=C5)C=C4)CC2

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...